null Option on Tenaya Therapeutics
| TNYA Stock | USD 0.85 0.01 1.08% |
Tenaya Therapeutics' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 2.5 with a put-to-call open interest ratio of 0.1 over 14 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 10.0, with calls trading at the volume of 146. This yields a 0.07 put-to-call volume ratio.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Tenaya Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Tenaya Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Tenaya Therapeutics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Tenaya Therapeutics
Analyzing Tenaya Therapeutics' in-the-money options over time can help investors to take a profitable long position in Tenaya Therapeutics regardless of its overall volatility. This is especially true when Tenaya Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Tenaya Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Tenaya Therapeutics' stock while costing only a fraction of its price.
Tenaya Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Tenaya Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Tenaya stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Tenaya Therapeutics' stock price goes up or down, the stock options follow.
At present, Tenaya Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 196.1 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 57.4 M. Tenaya Therapeutics In The Money Call Balance
When Tenaya Therapeutics' strike price is surpassing the current stock price, the option contract against Tenaya Therapeutics stock is said to be in the money. When it comes to buying Tenaya Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Tenaya Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Tenaya Current Options Market Mood
Tenaya Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Tenaya Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Tenaya Therapeutics' options investors are not very successful. Tenaya Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Tenaya contract
Base on the Rule 16, the options market is currently suggesting that Tenaya Therapeutics will have an average daily up or down price movement of about 0.16% per day over the life of the 2025-10-17 option contract. With Tenaya Therapeutics trading at USD 0.85070002, that is roughly USD 0.001329. If you think that the market is fully incorporating Tenaya Therapeutics' daily price movement you should consider buying Tenaya Therapeutics options at the current volatility level of 2.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Tenaya Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Tenaya calls. Remember, the seller must deliver Tenaya Therapeutics stock to the call owner when a call is exercised.
Tenaya Therapeutics Option Chain
When Tenaya Therapeutics' strike price is surpassing the current stock price, the option contract against Tenaya Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Tenaya Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Tenaya. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Tenaya. It also shows strike prices and maturity days for a Tenaya Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | TNYA251017C00007500 | 24 | 7.5 | 0.0 - 0.45 | 0.45 | Out |
Call | TNYA251017C00005000 | 29 | 5.0 | 0.0 - 0.75 | 0.75 | Out |
Call | TNYA251017C00002500 | 53 | 2.5 | 0.0 - 0.1 | 0.05 | Out |
Call | TNYA251017C00002000 | 146 | 2.0 | 0.0 - 1.0 | 0.1 | Out |
Call | TNYA251017C00001500 | 173 | 1.5 | 0.05 - 0.15 | 0.05 | Out |
Call | TNYA251017C00001000 | 1264 | 1.0 | 0.15 - 0.3 | 0.2 | Out |
Call | TNYA251017C00000500 | 1200 | 0.5 | 0.35 - 0.45 | 0.4 | In |
Put | TNYA251017P00007500 | 0 | 7.5 | 6.5 - 6.9 | 6.5 | In |
Put | TNYA251017P00005000 | 0 | 5.0 | 2.6 - 4.5 | 2.6 | In |
Put | TNYA251017P00002500 | 0 | 2.5 | 0.0 - 4.5 | 4.5 | In |
Put | TNYA251017P00002000 | 0 | 2.0 | 0.9 - 1.4 | 0.9 | In |
Put | TNYA251017P00001500 | 67 | 1.5 | 0.7 - 0.95 | 0.7 | In |
Put | TNYA251017P00001000 | 20 | 1.0 | 0.0 - 0.7 | 0.7 | In |
Put | TNYA251017P00000500 | 216 | 0.5 | 0.0 - 0.1 | 0.07 | Out |
Tenaya Total Stockholder Equity
Total Stockholder Equity |
|
Tenaya Therapeutics Corporate Management
| Deepak MD | Chairman Founder | Profile | |
| Saptarsi MD | Scientific Founder | Profile | |
| Chihiro Saito | Senior Officer | Profile | |
| Tomohiro MBA | Senior Officer | Profile | |
| KeeHong Kim | Chief Officer | Profile | |
| Jennifer JD | General Secretary | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.